4-(1 H -Benzoimidazol-2-yl)-phenylamine, 95.0%, 250mg

4'-Nitro-[1,1'-biphenyl]-4-carbaldehyde, 95.0%, 25g

(6Z,9Z,28Z,31Z)-Heptatriaconta-6,9,28,31-tetraen-19-yl 4-(Dimethylamino)butanoate>85.0%(HPLC)(T)250mg

4,5-Dibromo-o-xylene, 98.0%, 500g

3-Chlorobenzoic acid, >=98%, for synthesis, 500 g, plastic packaging.

tert-Butyl 4-cyano-4-(4-fluorobenzyl)piperidine-1-carboxylate, 95.0%, 250mg

N,N'-Bis(salicylidene)ethylenediamine, 98%, 500g

4,8-Dichloro-6-nitro-quinoline-3-carbonitrile, 95.0%, 250mg

4-Chlorothieno[2,3-b]pyridine, 97%, 5g

2-Chloroethyltriethoxysilane,95%, 95%, 100g

tert-Butyl (3-hydroxypyridin-2-yl)carbamate, 97.0%, 1g

(R)-5-Bromo-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-2-amine, 95.0%, 25g

7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazole, 95%, 10g